The mammalian gonadotropin-inhibitory hormone (GnIH) ortholog, RFamide-related peptide (RFRP), is considered to act on gonadotropin-releasing hormone (GnRH) neurons and the pituitary to inhibit gonadotropin synthesis and release. However, there is little evidence documenting whether RFamiderelated peptide 3 (RFRP-3) plays a primary role in inhibition of the hypothalamo-pituitary-gonadal (HPG) axis prior to the onset of puberty. The present study aimed to understand the functional significance of the neuropeptide on pubertal development. The developmental changes in reproductive-related gene expression at the mRNA level were investigated in the hypothalamus of female mice. The results indicated that RFRP-3 may be an endogenous inhibitory factor for the activation of the HPG axis prior to the onset of puberty. In addition, centrally administered RFRP-3 significantly suppressed plasma luteinizing hormone (LH) levels in prepubertal female mice. Surprisingly, centrally administered RFRP-3 had no effects on plasma LH levels in ovariectomized (OVX) prepubescent female mice. In contrast, RFRP-3 also inhibited plasma LH levels in OVX prepubescent female mice that were treated with 17beta-estradiol replacement. Our study also examined the effects of RFRP-3 on plasma LH release in adult female mice that were ovariectomized at dioestrus, with or without estradiol (E 2 ). Our results showed that the inhibitory effects of RFRP-3 were independent of E 2 status. Quantitative real-time PCR and immunohistochemistry analyses showed that RFRP-3 inhibited GnRH expression at both the mRNA and protein levels in the hypothalamus. These data demonstrated that RFRP-3 could effectively suppress pituitary LH release, via the inhibition of GnRH transcription and translation in prepubescent female mice, which is associated with estrogen signaling pathway and developmental stages. development, gonadotropin-inhibitory hormone, hypothalamic hormones, luteinizing hormone, steroid hormones
INTRODUCTION
The hypothalamo-pituitary-gonadal (HPG) axis integrates internal and external cues via a balance of stimulatory and inhibitory neurochemical systems to regulate reproductive function in mammals. The cumulative balance of these neurochemical systems ultimately drives the pattern of gonadotropin-releasing hormone (GnRH) secretion. GnRH acts on the anterior pituitary to control the release of gonadotropins, luteinizing hormone (LH) and follicle-stimulating hormone (FSH), which in turn regulate steroidogenesis and gametogenesis, respectively, allowing not only the timed control of reproduction but also its coupling with other essential bodily functions [1, 2] . GnRH expression varies significantly throughout the animal's life; it is present and active at birth, but GnRH is not released until the onset of puberty [3] . However, it is not known what stimulates the initial increase in GnRH secretion at puberty, or alternatively, what inhibits GnRH secretion until the onset of puberty.
Our knowledge of the major neuroendocrine pathways controlling mammalian reproduction has substantially expanded recently. Kisspeptin, a hypothalamic peptide coded by the Kiss1 gene, is a novel neuromodulator that acts upstream of GnRH and is sensitive to sex steroid feedback and metabolic cues. During the past decade, evidence has demonstrated that kisspeptin and its receptor, GPR54, exert a critical stimulatory role for the onset of puberty and reproductive function [4] [5] [6] [7] . However, an inhibitory hypothalamic neuropeptide for gonadotropin secretion was unknown until recently, although gonadal sex steroids and inhibin can modulate gonadotropin secretion. In 2000, the Japanese group of Tsutsui et al. [8] identified a novel hypothalamic dodecapeptide (SIK-PSAYLPLRF-NH 2 ) in the Japanese quail and termed it gonadotropin-inhibitory hormone (GnIH); this was shown to inhibit gonadotropin secretion through its G protein-coupled receptor 147 (GPR147) at the hypothalamic level. The mammalian ortholog of avian GnIH, termed RFamide-related peptide (RFRP), encodes a precursor that produces two peptides, RFRP-1 and RFRP-3 [9] [10] [11] [12] [13] . RFRP-3 is located in neurons of the paraventricular nucleus and dorsomedial hypothalamic, and their terminals in the median eminence [14, 15] . It was shown that RFRP-3 inhibits gonadotropin release in vitro and in vivo in hamsters [14, 16] , mice [17, 18] , and rats [15, 19] . RFRP-3 also reduced GnRH-stimulated gonadotropin secretion in sheep [20] and pulsatile gonadotropin secretion in cattle [21] . It was also reported that intracerebroventricular (I.C.V.) 1-adamantanecarbonyl-ArgPhe-NH2 trifluoroacetate salt (RF9) injection, an antagonist of the RFRP-3 receptor, evoked a large increase in LH and FSH secretion in mice, rats, and sheep, regardless of breeding 1 Supported by the National Natural Science Foundation of China (grant No. 31372287), the Ministry of Agriculture transgenic major projects of China (2014ZX0800952B), the Agricultural Science and Technology Innovation Program of China (ASTIP-IAS13), and the National Biological Breeding Capacity Building and Industrialization Projects (2014-2573). 2 Correspondence: E-mail: wang_pq@21cn.com season or gonadal status [22] [23] [24] [25] . Thus, RFRP-3 is considered to act as an important inhibitory hypothalamic neuropeptide to control reproduction in mammals. However, most researchers have focused on the effects of RFRP-3 on gonadotropin release in mature mammals; whether RFRP-3 plays a primary role in the HPG prior to the onset of puberty is unclear. We speculated that RFRP-3 may be a prime candidate to fill this role as an endogenous inhibitory factor for the activation of HPG, and thus puberty.
The GnRH neuronal system, which represents the final common pathway in the neuroendocrine control of reproduction, responds to feedback actions of circulating 17b-estradiol. During the preovulatory period, high levels of estrogen are secreted from the mature follicles, resulting in GnRH/LH surge via a positive feedback effect [26] . However, the GnRH neurons do not express alpha estradiol receptors (ER a ), suggesting that estrogen negative feedback is exerted via a separate set of intermediary neurons [26] . Evidence that the RFRP neuronal system may be involved in estrogen feedback signaling to GnRH neurons has emerged from several studies. A previous study showed that about 18% of RFRP neurons expressed ERa in the brain of ovariectomized (OVX) mouse [14] . In addition, RFRP neurons contain ERa expression [13] and respond with c-Fos expression to an acute administration of 17b-estradiol in Siberian hamster [13] . It is worth noting that the total expression of RFRP mRNA in proestrus was lower than in diestrus in mice, and the number of neurons expressed RFRP peptide in proestrus and early estrus was lower than that in estrus and diestrus in rats [27, 28] . Furthermore, in situ hybridization results showed that estradiol (E 2 ) implants (100 lg/ml) for 4 days decreased the number of RFRP cells and the expression of RFRP mRNA per cell in ovariectomized mice [29] . However, there is no evidence confirming whether the inhibitory effect of RFRP-3 on gonadotropin release involves E 2 -dependent mechanisms in mammals. Therefore, additional studies are needed to clarify the mechanism of sex steroid actions on RFRP neurons.
In this study, we hypothesized that RFRP-3 inhibits GnRH/ LH secretion before the onset of puberty, thus affecting reproduction. To assess the functional significance of RFRP-3 in prepubescent mammalians, we first determined the developmental changes in reproduction-related gene expression at the mRNA level in the hypothalamus of mice by quantitative real-time PCR. Second, we were interested in determining the effects of RFRP-3 on gonadotropin release by the injection of exogenous reagents. Quantitative real-time PCR detected hypothalamic reproductive genes' mRNA expression, and immunohistochemistry tested the peptide levels of GnRH neuron. Finally, we investigated whether the effects of RFRP-3 were related to estrogen status and developmental stages.
MATERIALS AND METHODS

Animals and Drugs
Prepubescent female BALB/C mice (16-18 g) were used. All animals were purchased from the Experimental Animal Center of the Third Military Medical University at 24 to 28 days of age and were allowed several days to acclimate to the laboratory conditions prior to the start of manipulations. Animals were housed in translucent polypropylene cages and provided ad libitum access to food and water for the duration of the study. Animals were maintained in a colony room at 258C 6 18C with a 12L:12D cycle (lights on at 0900 h and lights off at 2100 h). All animals were cared for and experiments were carried out in accordance with the Asian Community guidelines for the use of experimental animals. All of the protocols in this study were approved by the Ethics Committee of Chongqing University, China.
Mouse RFRP3-8 and kisspeptin were synthesized by Shanghai Apeptide Co Ltd. Mouse anti-GnRH antibody (ab16216) and anti-Kisspeptin antibody (AB9754) were purchased from Abcam and Merck Millipore, respectively. RF9, an antagonist of the RFRP-3 receptor, was purchased from Sigma Chemical. The drugs were dissolved in saline (0.9% NaCl). Doses for hormonal analyses were selected on the basis of previous studies [22] .
Intracerebroventricular Injections
BALB/C mice were anesthetized using a 7% chloral hydrate and positioned in the stereotaxic apparatus. The head of the animal was shaved and prepared for aseptic surgery. A single incision was made on the midline of the scalp. Once the area had been prepped, a stainless steel 30-gauge cannula was placed in the lateral ventricle at 1.2 mm lateral to the midline, 0.5 mm posterior to the bregma, and 2.5 mm inferior to the dura mater, as previously described [17] .
Ovariectomy, Hormone Treatments, and Blood and Tissue Collection
Mice were anesthetized with 7% chloral hydrate and bilaterally ovariectomized, and they were treated with 17b-estradiol (OVX þ E 2 ) or benne oil replacement. One week after ovariectomy, animals were anesthetized with pentobarbital and killed by decapitation. Blood was collected from the bulbus oculi into a tube and centrifuged at 3000 rpm for 15 min at 48C to separate serum, and it was stored at À208C for the ELISA of LH. Brains were rapidly removed from the skull, snap-frozen at À208C, and stored at À808C for subsequent RNA extraction and immunohistochemistry. XIANG ET AL.
Quantitative Real-Time PCR
For the measurement of hypothalamic reproduction-related genes' mRNA, the hypothalamus was dissected along the following boundaries: laterally 1.2 mm on either side of the third ventricle, from the optic chiasm to the posterior border of the mammillary bodies, and the thalamus dorsally ( Fig. 1) . Total RNA was isolated from the dissected hypothalamus using a TRIzol reagent kit (TaKaRa) and an RNeasy Mini kit (TaKaRa). Complementary DNA was synthesized with oligo (deoxythymidine) primers using the SuperScript III First-Standard Synthesis System for RT-PCR (Invitrogen Co.). Real-time PCR analysis was performed using the PCR System 7500 (Promega) and SYBR green. Standard curves, generated from at least three dilution series of an abundant sample, were used for the relative quantification of hypothalamusrelated genes and b-actin (the same sample was used to generate standard curves for these genes). The expression levels of hypothalamus-related genes were normalized by dividing by b-actin mRNA expression levels (primers are shown in Table 1 ). Dissociation curve analysis was also performed for each gene at the end of PCR. Each amplicon generated a single peak. The forward and reverse primers used are listed in Table 1 . The PCR cycling conditions were as follows: initial denaturation and enzyme activation at 958C for 30 sec, followed by 40 cycles of denaturation at 958C for 5 sec, and annealing at 608C for 30 sec.
Immunohistochemistry
Brains were dissected out after whole-body perfusion, postfixed, passed through a graded series of alcohol, and embedded in paraffin wax. Threemicrometer-thick coronal sections of the brain passing through the preoptic area (POA) were deparaffinized in xylene, rehydrated, and rinsed in PBS (0.01 M, pH 7.4). Immunohistochemistry of peptides was performed by the following method. In brief, endogenous peroxidase activity was eliminated from the sections by incubation with 0.3% H 2 O 2 in absolute methanol for 20 min. After blocking nonspecific binding components with 5% normal goat serum in PBS for 1 h at room temperature, the sections were immersed in a 1:1000 dilution of primary antiserum raised against mouse GnRH for 16-20 h at 48C. Slides were rinsed in PBS and incubated with a 1:1000 dilution of horseradish peroxidaseconjugated secondary antibody, followed by another set of washes. Sections were then incubated for 1 h in avidin-biotin complex. After washing with TrisHCl, the staining was stopped by washing in distilled water. Sections were dehydrated through an ethanol series, cleaned in xylene, and mounted using DAB (a mixture of distyrene, a plasticizer, and xylene). Slides were viewed under a microscope (Axioskop 2 Plus; Carl Zeiss AG), and images were captured using a digital camera.
Hormone Assays
The trunk blood was collected by bulbus oculi, and plasma samples were obtained by centrifugation. All plasma concentrations of LH and FSH were determined by ELISA [30] .
Experiment 1: Developmental Changes in Hypothalamic Reproduction-Related Gene mRNA Expression in Female Mice
In order to characterize the developmental changes in the hypothalamic mRNA expression levels of reproductive genes, the hypothalamic samples were obtained from female (n ¼ 4 per age) mice at different ages, that is, Postnatal Days 24, 28, and 32, vaginal opening (VO), and Postnatal Day 50. Animals were decapitated as described above between 0900 and 1000 h, blood samples were centrifuged, plasma was stored at À208C until LH concentrations were measured, and whole brains were obtained and used for the measurement of hypothalamic reproductive genes' mRNA levels.
Experiment 2: Effect of RFRP-3 on Gonadotropin Release in Prepubescent Female Mice
It has been shown that RFRP-3 inhibits gonadotropin release in vitro and in vivo in several adult mammalians. Until now, however, there was little evidence confirming the effect of RFRP-3 on gonadotropin release in prepubescent mice. Therefore, we first tested whether RFRP3-8 can effectively suppress gonadotropin release in prepubescent mice. Five prepubescent female mice in the RFRP3-8 group were injected with 20 nmol of RPRP3-8 I.C.V., and five mice in the control group were injected with saline. The injection volume was 5 ll in both groups. Four hours after injection, blood samples were NEUROENDOCRINOLOGY AND REPRODUCTION centrifuged, and plasma was stored at À208C until LH and FSH concentrations were measured. Brains were rapidly removed from the skull, snap-frozen at À208C, and stored at À808C for subsequent RNA extraction.
Experiment 3: The Effect of RFRP-3 on Gonadotropin Release Was Associated with E 2 Status and Developmental Stages in Female Mice
The effects of E 2 on the RFRP-3 signaling pathway are unclear and not fully characterized. Therefore, our study tested whether E 2 status played a role in the inhibitory effect of RFRP3-8 on LH release in prepubescent mice. To further determine whether the potential physiological role of RFRP3-8 on gonadotropin release is associated with developmental stage, we also examined the effect of RFRP3-8 on gonadotropin release in adult female mice with or without E 2 . Prepubescent female mice were ovariectomized at Postnatal Day 21 and constantly intrapertoneally injected with either 17b-estradiol or benne oil (n ¼ 5 per group) every day. Similarly, adult female mice were ovariectomized at diestrus, and constantly intrapertoneally injected with either 17b-estradiol or benne oil (n ¼ 5 per group) every day. One week later, mice were injected with 20 nmol of RFRP3-8 or saline (n ¼ 5 animals per group) with or without E 2 replacement. Four hours after injection, blood samples were centrifuged, and plasma was stored at À208C until LH concentrations were measured. Brains were rapidly removed from the skull, snap-frozen at À208C, and stored at À808C for subsequent RNA extraction.
Statistical Analysis
All results are shown as mean 6 SEM. Statistical analyses were performed with SPSS 12.0 software. Data were analyzed by t-test or one-way ANOVA, followed by post hoc analysis: Tukey honestly significant difference test, as appropriate. Statistical significance was set at P , 0.05.
RESULTS
Experiment 1: Developmental Changes in Hypothalamic Reproduction-Related Gene Expression in Female Mice
To verify the hypothesis that RFRP-3 could inhibit the HPG axis prior to the onset of puberty, this experiment detected the developmental changes in hypothalamic reproduction-related gene expression in female mice. Indeed, the plasma LH concentrations increased gradually during prepuberty and peaked at vaginal opening (data not shown), which is in accordance with previous studies [31] . In addition, the hypothalamic reproduction-related gene expression changed significantly with age in female mice. RFRP and its cognate receptor GPR147 gene expression increased at Postnatal Days 28 and 32, respectively, and both peaked at Postnatal Day 32. However, the expressions of both molecules decreased at vaginal opening and were significantly lower than their peak values (Fig. 2, A and B) , and they were slightly increased at Postnatal Day 50. In addition, Kiss1 gene expression increased gradually until the onset of puberty in female mice, and it declined thereafter (Fig. 2C) , whereas its cognate receptor GPR54 gene expression increased at Postnatal Day 28, peaked at Postnatal Day 32, and then declined at vaginal opening day (Fig. 2D) . These results indicated that RFRP-3 may be an 
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endogenous inhibitory factor for the activation of the HPG prior to the onset of puberty.
Experiment 2: Effect of RFRP-3 on Gonadotropin Release in Prepubescent Female Mice
Based on studies in rats and sheep, RFRP-3 is considered an inhibitor of the gonadotrophic axis, through the blockade of GnRH release [14, 20, 22, 32] . However, there was no evidence confirming the inhibitory effect of RFRP-3 on gonadotropin release in prepubescent mice. In order to do this, the effects of I.C.V. RFRP3-8 treatment on gonadotropin release were initially examined in prepubescent mice. First, to determine the optimal action time of RFRP3-8 on plasma LH release, the experiment examined the plasma LH level at 1, 4, and 24 h after I.C.V. injection, the results indicated that 4 h after ICV injection is the optimal action time (Fig. 3A) . In addition, RFRP3-8 reduced plasma LH levels 4 h after injection in a dose-dependent manner, with the 500-ng dose giving the maximal response (Fig. 3B) .
As expected, centrally administered RFRP3-8 (500 ng) significantly suppressed plasma LH levels in prepubertal female mice. In contrast, centrally administered RF9, an antagonist of the RFRP-3 receptor, remarkably increased plasma LH levels. Similarly, Kisspeptin (KP-10) elicited significant elevations of plasma LH levels, which was used as a positive control (vehicle-injected group, 3.305 6 0.133 mIU/ml vs. Kisspeptin-injected group, 4.153 6 0.211 mIU/ml; RF9-injected group, 3.941 6 0.077 mIU/ml; and RFRP3-8-injected group, 2.497 6 0.122 mIU/ml; n ¼ 4 per group; P , 0.05; Fig. 4A) . Surprisingly, none of the compounds had a significant effect on plasma FSH secretion in prepubertal female mice compared with the vehicle-injected group (vehicle-injected group, 3.352 6 0.289 mIU/ml vs. Kisspeptin-injected group, 3.4773 6 0.385 mIU/ml; RF9-injected group, 3.592 6 0.236 mIU/ml; RFRP3-8-injected group, 3.194 6 0.111 mIU/ml; n ¼ 4 per group; Fig. 4B ).
To determine whether GnRH and kisspeptin neurons are targets for the central action of RFRP3-8 in female mice, the effects of RFRP3-8 on GnRH and KISS1 gene expression were examined in the hypothalamus of female mice. Infusion of RFRP3-8 resulted in a significant decrease in GnRH gene expression relative to the control group, whereas RF9 elicited significant elevations of GnRH mRNA levels (Fig. 5A ). In addition, centrally administered RFRP3-8 significantly reduced KISS1 but not GPR54 gene expression in the hypothalamus. In contrast, centrally administered RF9 dramatically inhibited both GPR147 and its receptor GPR54 gene expression, but had no effect on Kiss1 expression (Fig. 5, B-D) . However, none of these administrations had an effect on ERa mRNA expression in the hypothalamus (data not shown). To determine whether GnRH peptide levels were reduced by RFRP3-8 treatment, this experiment performed immunohistochemistry on tissue from the POA of prepubertal female mice. Similar to GnRH mRNA levels in the hypothalamus, the GnRH peptide levels were decreased in the POA with RFRP3-8 administration, compared with the control group (Fig. 6, A-D) . Clusters of immunoreactive perikarya were found in the POAs of all experimental mice. The number of immunoreactive-labeling GnRH cells tended to decrease, but not significantly, with RFRP3-8 administration in prepubertal female mice (Fig. 6G) . Surprisingly, quantitative analyses showed that the density of immunoreactive staining per GnRH neuron was significantly decreased compared with the control group (Fig. 6H) . Preadsorbed control section for GnRH showed no immunoreactivity (Fig. 6, E and F) . These results indicated that RFRP3-8 could efficiently suppress LH release in prepubescent mice through the blockade of GnRH transcription and translation. Given that RFRP neurons express ERa, and its expression is modulated by the E 2 feedback signaling pathway, this experiment investigated whether 17b-estradiol participates in the inhibitory effect of RFRP3-8 on LH release in prepubescent mice. In order to exclude the possibility that E 2 status affected the physiological efficiency of RFRP3-8, all mice of this experiment were ovariectomized bilaterally. Surprisingly, centrally administered RFRP3-8 had no effect on plasma LH levels in OVX prepubescent female mice (Fig. 7A) . In contrast, RFRP3-8 also inhibited plasma LH levels in OVX prepubescent female mice with 17b-estradiol replacement (Fig. 7A) . This result indicated that the effects of RFRP3-8 administration on the gonadotrophic axis may be dependent on sex hormones, at least in prepubescent female mice. In addition, this experiment determined whether the effects of RFRP-3 on LH release are involved in age-dependent effects in adult female mice. The effects of RFRP3-8 on plasma LH release were detected in adult female mice with or without 17b-estradiol replacement (Fig. 7B) ; the results showed that the inhibitory effects of RFRP3-8 were independent of E 2 in adult female mice.
DISCUSSION
GnIH, a newly discovered hypothalamic RFamide peptide, inhibited gonadotropin release and its synthesis in vitro and in vivo in birds [8, [33] [34] [35] ; this acted directly on the pituitary via a novel G-protein-coupled receptor, GPR147. RFRP-3, a mammalian GnIH homolog, has been identified in several mammalian species, such as rats [15, 19] , hamsters [14, 16] , sheep [20] , cows [21] , and pigs [36] . GnIH and RFRP-3 share a common C-terminal LPXRFamide motif. Therefore, it was considered that RFRP-3 might be an important factor in inhibiting gonadotropin release in mammals, similar to the action of GnIH in birds. Indeed, previous data indicate that RFRP-3 acted not only on the pituitary, but also on GnRH neurons in the hypothalamus via GPR147-inhibited gonadotropin synthesis and release, and gonadal development and maintenance in mammals [37, 38] . However, whether the inhibition of LH secretion by RFRP-3 occurs at the pituitary level or the hypothalamus level in mammals is unclear. Surprisingly, a recent study demonstrated that RFRP-3 exerted a stimulatory effect on the reproductive axis in the male Syrian XIANG ET AL.
hamster, most likely via hypothalamic targets [39] . In addition, there was little evidence of whether RFRP-3 played a primary role in the prepubertal inhibition of the HPG prior to the onset of puberty. Recently, a study has shown that the central administration of RFRP-3 significantly reduced LH release in rats, but interestingly had no effect on the onset of puberty [3] . Therefore, additional research is needed to clarify whether RFRP-3 efficiently suppressed the HPG axis in prepubertal mammals.
The present study aimed to determine the physiological effects of RFRP-3 on gonadotropin release at the hypothalamus level in prepuberty female mice. Additionally, whether E 2 status and developmental stages modulate the inhibitory effect of RFRP-3 was examined. Firstly, this experiment detected the developmental changes in hypothalamic reproduction-related gene expression in female mice. Recently, studies have demonstrated the developmental changes in the hypothalamic mRNA of RFRP and GPR147 in rats [31, 39] , and their results for RFRP mRNA roughly corresponded to ours. Namely, the mRNAs of RFRP and its receptor genes increased gradually during prepuberty, with both peaking at Day 32 and then decreasing at vaginal opening, which is the sign of puberty onset. These results suggest that the hypothalamic RFRP system changes during development and that RFRP may play an important role in sexual maturation.
To clarify the functional roles of the RFRP system during prepuberty in female mice, this experiment directly investigated the roles of RFRP-3 on gonadotrophic secretion in female mice. In accordance with previous studies, RFRP3-8 infusion had a significant inhibitory effect on plasma LH levels in prepubertal mice, whereas centrally administered RF9 remarkably increased plasma LH levels. These results demonstrate that RFRP-3 indeed exerted a central inhibitory effect on the HPG axis prior to the onset of puberty. It is interesting to remark that neither RFRP-3 nor RF9 administration changed plasma FSH secretion in prepubertal female mice compared with the control group. This could be explained by the fact that FSH may exert a secondary role in prepubertal mice. In addition, to further determine whether RFRP-3 inhibited gonadotropin release at the hypothalamus level, this experiment examined the effects of RFRP-3 on hypothalamus-related gene expression in prepubertal female mice. Indeed, the infusion of RFRP3-8 significantly decreased GnRH mRNA expression, whereas RF9 had an opposite effect. Furthermore, the role of RFRP-3 on GnRH expression at the protein level was detected in the POA. Similar to GnRH mRNA levels at the hypothalamus level, RFRP3-8 infusion not only tended to decrease the number of GnRH immunoreactive cell bodies, but also significantly reduced the immunoreactive staining per GnRH neuron in the POA. These results further demonstrated that RFRP-3 could inhibit the HPG axis prior to the onset of puberty, through the blockade of GnRH transcription and translation. Our study directly provided novel evidence that RFRP-3 inhibited gonadotropin release at the hypothalamic level, but it does not exclude a role for RFRP-3 at the pituitary level.
Many neuropeptide systems are regulated by hormones, but contradictory outcomes currently exist regarding the roles of sex steroids in regulating RFRP neurons [40] . Estradiol treatment either had no effect on RFRP expression in female rats [31] or decreased total RFRP levels in female mice [30] . In addition, the degree of coexpression of sex steroid receptors in RFRP-3 neurons was different in various species [14, 30] . Furthermore, how the interplay occurs between the inhibitory effect of RFRP-3 and the E 2 negative feedback signaling pathway is unclear. To determine this, the current experiment investigated whether the inhibitory effect of RFRP-3 on LH release is related to 17b-estradiol in prepubescent mice. Surprisingly, RFRP-3 infusions did not affect LH secretion in OVX prepubertal female mice. To further support this idea, we carried out I.C.V. injections of RFRP-3 in OVX female mice that had received E 2 replacement. It was shown that RFRP-3 restored the inhibitory role in plasma LH secretion, suggesting that the effects indeed depend on the E 2 physiological status of the species, at least in prepubescent female mice. Thus, further research is needed to clarify whether E 2 negative feedback is involved in the inhibition of RFRP-3 on reproductive function in mammals. Interestingly, it has been shown that the effect of RFRP-3 on reproduction was sex dependent and developmental status dependent in the striped hamster [41] . Therefore, our study also examined the effects of RFRP-3 on plasma LH release in OVX adult female mice with or without E 2 . The results showed that the inhibitory effects of RFRP-3 are independent of E 2 in adult female mice. This result indicated that the inhibitory effects of RFRP-3 may be associated with developmental stages. Our study provided new evidence that the effect of RFRP-3 on gonadotropin release depends on E 2 status, which was associated with developmental stages. However, the way in which E 2 signaling pathway and developmental stages modulate the effect of RFRP-3 on gonadotropin release needs further research.
In summary, the present study provided novel evidence that RFRP-3 plays a critical inhibitory role in gonadotropin release in prepubertal mice, and thereby puberty and reproduction. Our NEUROENDOCRINOLOGY AND REPRODUCTION study demonstrated that RFRP-3 could suppress plasma LH release, depending on E 2 status, at least in prepubertal female mice. Moreover, it was also shown that the inhibitory effects of RFRP-3 are associated with developmental stage. Overall, these data demonstrate that RFRP-3 effectively suppresses pituitary LH release depending on E 2 status, by directly or indirectly inhibiting GnRH transcription and translation in prepubescent female mice, which is associated with developmental stage. Our findings raise the question of whether sex hormone-dependent and developmental differences affect the role of RFRP-3 in the regulation of the reproductive function.
